Fundraising FoxMiracor Medical
9 known investors
Find your way into Miracor Medical
Sign up to find every way you can get introduced to Miracor Medical
- Your email: who you already know at Miracor Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Miracor Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.
Investors · 9
How we know: Delta Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Ming capital's portfolio page · Not right? Tell us
How we know: funding news · nordic9.com · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: nordic9.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ESep 2020
Earlybird, Noshaq, Quest for Growth, SFPI-FPIM, SRIW, Yonghua
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- MIRACOR MEDICAL UK LIMITED
- Company number
- 13351395
- Status
- Dissolved
- Company type
- Private limited company
- Incorporated
- 22 Apr 2021
- Dissolved
- 24 Dec 2024
- Registered office
- Fairbourne Drive, Atterbury, Milton Keynes, Buckinghamshire, MK10 9RG
- Nature of business (SIC)
- 26600 — Manufacture of irradiation, electromedical and electrotherapeutic equipment
- Accounts
- last made up to 30 Apr 2023
- Confirmation statement
- last made up to 21 Apr 2024
Current officers
- Olivier Delporte — director, appointed 22 Apr 2021
- Gillian Margaret Glennon — director, appointed 17 May 2021
- Bertrand Grimmonpre — director, appointed 22 Apr 2021
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Miracor Medical do?
- Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.
- Who are Miracor Medical's investors?
- Miracor Medical's investors include Delta Partners, Ming capital, Quest for Growth, SHS Capital, Yonghua Capital.